ID
22328
Descripción
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, This form is to be performed in/after Screening Period 1, Weeks 2, 1 Month +/- 3 Days, 2 Months, 4 Months, 6 Months +/- 1 week, 8 Months, 10 Months, 12 Months +/- 1 week and Follow Up. Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Palabras clave
Versiones (2)
- 30/5/17 30/5/17 -
- 30/5/17 30/5/17 -
Subido en
30 de mayo de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Descripción
Investigational Product Compliance
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Descripción
Investigational Product
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0304229
Descripción
Start date
Tipo de datos
date
Unidades de medida
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0304229
Descripción
Stop Date
Tipo de datos
date
Unidades de medida
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0304229
Descripción
IP Container No.
Tipo de datos
float
Alias
- UMLS CUI [1,1]
- C0180098
- UMLS CUI [1,2]
- C0304229
Descripción
Total number of Tablets Dispensed
Tipo de datos
float
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0039225
Descripción
Total number of Tablets Returned
Tipo de datos
float
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Descripción
Discontinuation
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0304229
Similar models
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
C0011008 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])